Geopolitics Alpha

8-K - Silexion Therapeutics Corp (0002022416) (Filer)

Published . Updated .

Key takeaways

  • 8-K - Silexion Therapeutics filed an 8-K with the SEC on Oct 26 (a notice of a material company event).
  • Exposed: SLXNW
  • Market reaction: SLXNW 0.0% after two sessions

Market Call

Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.

Get these market calls by email

The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.

Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.

GEOPOLITICS ALPHA8-K - Silexion Therapeutics Corp(0002022416) (Filer)SLXNGEOPOLITICS ALPHA

8-K - Silexion Therapeutics filed an 8-K with the SEC on Oct 26 (a notice of a material company event).

Directly affected

  • SLXN Silexion Therapeutics

    Named in this report.

Indirectly affected

  • No related companies are mapped for this report yet.

Price reaction, T-5 to T+3

TickerT-5T-3T-1T0T+1T+2T+3
SLXN-11.67%-7.82%base-5.30%-14.74%-16.14%-18.31%

Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.

Filed: 2026-10-26 AccNo: 0001178913-26-004849 Size: 251 KB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements a…

Source: sec-edgar

Price since this story was published: Silexion Therapeutics (SLXNW)

CompanyWhenMoveStatus
SLXNthat day-5.30%final price
SLXNthe next day-14.74%final price
SLXNtwo days later-16.14%final price
SLXNthree days later-18.31%final price
SLXNthree days earlier-7.82%final price
SLXNfive days earlier-11.67%final price

Who is named in “8-K - Silexion Therapeutics Corp (0002022416) (Filer)”

Companies mentioned with this story

  • SLXNW Silexion Therapeutics

    In “8-K - Silexion Therapeutics Corp (0002022416) (Filer),” Silexion Therapeutics (SLXNW) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> SLXNW

How “8-K - Silexion Therapeutics Corp (0002022416) (Filer)” reaches Silexion Therapeutics (SLXNW)

Silexion Therapeutics (SLXNW) is the company in “8-K - Silexion Therapeutics Corp (0002022416) (Filer),” the 26 Oct 2026 this story story.

For Silexion Therapeutics (SLXNW), the reason on file says SEC 8-K filing -> direct issuer disclosure -> SLXNW

What the saved facts support for Silexion Therapeutics (SLXNW)

14 out of 100

“8-K - Silexion Therapeutics Corp (0002022416) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.